Both organic and inorganic forms of selenium are utilized in the biosynthesis of selenoproteins. Selenite is taken up by red blood cells and then returned to the plasma after reduction, but little is known about the metabolic fate of selenocysteine. We found that selenocysteine was taken up into red blood cells without decomposition into selenide.
The essential trace element selenium is incorporated in selenoproteins, [1] [2] [3] which are required for normal embryonic development, 4, 5) DNA biosynthesis, 6) redoxregulation of certain transcription factors, regeneration of several antioxidants, and cellular redox control. 7) Selenoproteins contain selenium in the form of a selenocysteine residue, which is co-translationally incorporated into a nascent polypeptide chain as directed by the UGA codon and tRNA
[Ser]Sec . 8) On the other hand, selenomethionine is nonspecifically incorporated in proteins. 9) Both selenocysteine and selenomethionine in proteins from foods serve as major sources of selenium for mammals and are absorbed by duodenum capillaries after digestion, in the same manner as other amino acids, but the subsequent fate of the seleniumcontaining amino acids in the blood is unclear. In contrast, uptake of selenite into red blood cells (RBCs) through the band 3 protein (anion exchanger 1, AE1) and its subsequent release into the plasma after reduction have been established. 10) It has been proposed that selenite is reduced by glutathione 11) and thioredoxin reductase 12) to yield selenide. 13, 14) In RBCs, the selenide formed from selenite by reduction is bound to hemoglobin (Hb), 15) but little is known about the interaction between Hb and selenium-containing amino acids. In this study, we examined to determine whether seleniumcontaining amino acids (selenocysteine, selenomethionine, and selenocystine) are absorbed by RBCs. The interaction between Hb and the selenium-containing amino acids was also investigated.
Male Std:Wistar rats (8 weeks old, from Shimizu Laboratory Supplies, Kyoto, Japan) were sacrificed by cervical dislocation. Blood was collected from the abdominal aorta using a syringe containing heparin. To investigate the uptake of selenium-containing amino acids by RBCs, heparinized whole blood was incubated with L-selenocysteine (5 mM, prepared by reducing L-selenocystine with a 40-mol excess of dithiothreitol, or DTT), L-selenocystine (2.5 mM), L-selenomethionine (5 mM), or sodium selenite (5 mM) at 37 C. RBCs were separated from the plasma by centrifugation at 8;000 Â g for 10 s, and were washed with phosphatebuffered saline (PBS, pH 7.4) twice. The amount of selenium in the RBCs was determined with 2,3-diaminonaphthalene, as described by Watkinson. 16) Differences in the amounts of selenium in the seleniumtreated RBCs were plotted against the incubation time. We found that selenocysteine was significantly taken up by RBCs (Fig. 1A) . Consistently with previous reports, 10) selenite was taken up by RBCs within few min, and then rapidly excreted into the plasma after reduction 17) (Fig. 1A) . Such excretion was not observed for selenocysteine. Selenomethionine and selenocystine were not significantly taken up by RBCs, suggesting that the uptake of selenocysteine into RBCs is selective. Prolonged incubation with selenoamino acids caused no marked change in selenium concentration in the RBCs. The differences in selenium concentration in RBCs when incubated with selenocysteine were 6.5 mM at 30 min, 5.2 mM at 60 min, and 6.4 mM at 120 min, when incubated with selenomethionine, they were À0:4 mM at 30 min, À0:1 mM at 50 min, and À0:4 mM at 100 min; and when incubated with selenocystine, À0:4 mM at 30 min, À0:7 mM at 50 min, and À1:3 mM at 100 min.
Since selenium reduced in RBCs is known to be excreted into the plasma and bound to albumin, 17) we assumed that selenide accumulates in RBCs in the absence of plasma. To confirm this, we examined the uptake of selenoamino acids by RBCs in PBS instead of plasma. Heparinized whole blood was centrifuged at 400 Â g for 15 min to separate RBCs from the plasma. The RBCs were washed in PBS, collected by centrifugation, resuspended at 50% v/v in PBS contain-
, and incubated at 37 C. The amount of selenium in the RBCs was determined as described above. As expected, selenium accumulated in the RBCs under incubation with selenite in the absence of plasma (Fig. 1B) . This suggests that albumin (and/or other factors) is required for the excretion of selenide from RBCs. Selenocysteine, but not selenocystine, was also taken up into the RBCs without significant subsequent return to PBS (Fig. 1B) . The rate of uptake of selenocysteine was lower in PBS than in plasma. This implies that an unidentified factor in plasma facilitates the uptake of selenocysteine into RBCs. A longer lag (about 3 min) in the uptake of selenocysteine was seen in the presence of plasma, possibly due to the occurrence of a molecule that competes with selenocysteine for uptake. The slight uptake of selenomethionine was likely due to amino acid transport system y þ L, which transports methionine, 18, 19) because the chemical properties of selenomethionine and methionine are similar.
To examine further the accumulation of selenocysteine in RBCs without efflux, RBCs incubated with selenocysteine in PBS, as described above, were collected and resuspended at 50% v/v in plasma. After incubation in the plasma, we determined the amount of selenium in the RBCs. The result clearly showed that selenocysteine-derived selenium did not efflux from RBCs in the plasma (data not shown). Because selenide derived from selenite in RBCs is excreted into the plasma, 17) this suggests that selenocysteine taken up into RBCs is not converted into selenide. AE1, the most abundant anion transporter in RBCs, is responsible for the uptake of selenite into RBCs, and uptake is inhibited by 4,4 0 -diisothiocyano-2,2 0 -stilbene disulfonate. 10) In general, amino acids are taken up via a transport system specific to amino acids. As expected, 4,4 0 -diisothiocyano-2,2 0 -stilbene disulfonate had no effect on the uptake of selenocysteine into the RBCs (data not shown).
In contrast, the uptake of selenocysteine decreased under incubation for 30 min with sodium azide, which depletes cellular ATP ( Fig. 2A) . This suggests that the uptake process is energy-dependent, and implies the association of an active transport process with selenocysteine uptake. In addition, uptake was inhibited by incubation with cysteine (Fig. 2B) . This further suggests that the uptake of selenocysteine is mediated by the cysteine transporter. 20) We also found that the amount of selenium taken up into the RBCs increased concomitantly with increasing concentrations of selenocysteine in the incubation mixture (Fig. 3A) . This indicates that the uptake of selenocysteine by RBCs is concentration-dependent.
Hb contains heme, which serves as the oxygenbinding site. 21) The heme also binds to carbon monoxide, cyanide, nitrogen dioxide, and sulfide. 22, 23) After uptake by RBCs, selenite undergoes reduction to form selenide, and then probably binds to Hb. 15) Since the selenol group of selenocysteine has low pK a (5.2) and is reactive, we investigated the affinity of selenocysteine and selenide for Hb. Bovine Hb (20 mM) was incubated with 20 mM selenocysteine or 20 mM selenide in PBS containing 500 mM DTT at 37 C for 1 min, followed by absorption spectrum measurement with a spectrophotometer (UV-2450 Shimadzu, Kyoto, Japan). Hb incubated with selenide exhibited a significant spectrum change, suggesting an interaction of selenide with heme (Fig. 3B) . In contrast, selenocysteine had no effect on the absorption spectrum of Hb, implying that selenocysteine does not bind to heme. The results of determination of the amount of Hb-bound selenium confirmed the binding of selenide, but not of selenocysteine, to Hb (data not shown). These results suggest that selenocysteine exists in a free form or binds to a component other than Hb in RBC.
In this study, we found that selenocysteine was taken up into RBCs via a potential transporter. Our results also indicate that selenocysteine is not decomposed to selenide in the RBCs, and therefore does not efflux from them. Although it is generally believed that both selenite and selenocysteine are converted into selenide, 24) our data suggest that the fate of selenocysteine is different from that of selenite in RBCs.
In conclusion, this study is the first demonstration of uptake of selenocysteine by RBCs, and it provides a clue to the metabolism of selenocysteine in blood. 
